Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns

Ashutosh Bhave

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (25)

  1. Magic of the Mushrooms: Effects of Psilocybin Decriminalization. 2025-01-01 · Expand citations
  2. Psychedelic Drug Legislative Reform and Legalization in the US. 2023-01-01 · Expand citations
  3. Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
  4. Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016. 2018-12-01 · Expand citations
  5. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. 2018-11-01 · Expand citations
  6. DARK Classics in Chemical Neuroscience: Psilocybin. 2018-10-17 · Expand citations
  7. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
  8. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. 2017-01-01 · Expand citations
  9. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  10. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  11. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
  12. Experienced drug users assess the relative harms and benefits of drugs: a web-based survey. 2013-01-01 · Expand citations
  13. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. 2011-11-01 · Expand citations
  14. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  15. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  16. OpenAlex W2015666695
  17. OpenAlex W2945519735
  18. OpenAlex W2966696030
  19. OpenAlex W3022718734
  20. OpenAlex W4210625095
  21. OpenAlex W4284991345
  22. OpenAlex W4380421146
  23. OpenAlex W4381839757
  24. OpenAlex W4383186683
  25. OpenAlex W4412161399

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.